Jichao Kang | BioProcess International

BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BPI Events About Subscribe Contribute

Upstream

Recent in Upstream

See all

Croda Pharma Ask the Expert

Sponsored Content

Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency

byBPI Contributor

Oct 29, 2024

1 Hr View

thumbnail

Gene Therapies

A Scale-Up/-Down Platform for Fast-Paced Upstream Process Development of rAAV-Based Gene Therapies A Scale-Up/-Down Platform for Fast-Paced Upstream Process Development of rAAV-Based Gene Therapies

byTereza Pavlištová, Maria João Alves Correiaand 5 more

Oct 17, 2024

Downstream

Recent in Downstream

See all

Bio-Rad BPI Ask the Expert Webcast

Sponsored Content

Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process

byBPI Contributor

Jan 28, 2025

15 Min View

Nagase special report

Sponsored Content

Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability Advanced Saccharide Solutions in Biopharmaceutical Development: Paving the Way for Product Stability and Environmental Sustainability

byYosuke Shimojo, Toshio Ariyasuand 1 more

Dec 9, 2024

Manufacturing

Recent in Manufacturing

See all

Innoforce

Sponsored Content

Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics

byBPI Contributor

Jan 23, 2025

30 Min View

The Framingham biomanufactuiring facility near Boston has received a US FDA warning letter

Facilities & Capacity

FDA cites contamination concerns in warning to Sanofi MA plant FDA cites contamination concerns in warning to Sanofi MA plant

byDan Stanton

Jan 22, 2025

3 Min Read

Analytical

Recent in Analytical

See all

Nirrin Technologies BPI Ask the Expert webinar

Sponsored Content

Big Impact From Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis Big Impact From Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis

byBPI Contributor

Jan 21, 2025

15 Min View

Assays eBook

Sponsored Content

eBook: Developing Assays — Considerations Across the Analytical Spectrum eBook: Developing Assays — Considerations Across the Analytical Spectrum

byCheryl Scott, Dana Ciprianoand 6 more

Dec 12, 2024

Business

Recent in Business

See all

Image of an entry of AZ's UK facilities near Liverpool that will no longer see a £450m expansion

Facilities & Capacity

Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant

byDan Stanton

Feb 3, 2025

2 Min Read

Ireland Hubs eBook

Sponsored Content

eBook: Insider Hubs — Ireland: Exploring an Evolving Biopharmaceutical Landscape eBook: Insider Hubs — Ireland: Exploring an Evolving Biopharmaceutical Landscape

byGareth Macdonald, Dan Stanton

Jan 22, 2025

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

Antibody-Drug Conjugate eBook

Sponsored Content

eBook: Antibody-Drug Conjugates — A Technology Update eBook: Antibody-Drug Conjugates — A Technology Update

byShreeyashi Ojha, Josh Abbottand 4 more

Jan 24, 2025

Cell Therapies Insider eBook

Sponsored Content

eBook: Advancing Autologous Cell Therapies — Collaboration is Key eBook: Advancing Autologous Cell Therapies — Collaboration is Key

byJason Bock

Nov 21, 2024

BioProcess Insider

Recent in BioProcess Insider

See all

Verdant farmland in the Austrian mountains

Upstream & Downstream Processing

Alois Jungbauer: A life in biotechnology Alois Jungbauer: A life in biotechnology

byJosh Abbott

Feb 3, 2025

3 Min Read

Image of an entry of AZ's UK facilities near Liverpool that will no longer see a £450m expansion

Facilities & Capacity

Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant

byDan Stanton

Feb 3, 2025

2 Min Read

Home
Jichao Kang

Jichao Kang

Latest from Jichao Kang

Rapid Formulation Development for Monoclonal Antibodies

Formulation

Rapid Formulation Development for Monoclonal Antibodies Rapid Formulation Development for Monoclonal Antibodies

byJichao Kang, Xi Linand 1 more

Apr 12, 2016

Replacing Reverse-Phase Chromatography for Mass Spectrometry: Is Salt-Free Size-Exclusion Chromatography Ready?

Formulation

Replacing Reverse-Phase Chromatography for Mass Spectrometry: Is Salt-Free Size-Exclusion Chromatography Ready?Replacing Reverse-Phase Chromatography for Mass Spectrometry: Is Salt-Free Size-Exclusion Chromatography Ready?

byXi Lin, Jichao Kang

Oct 16, 2014

All from Jichao Kang

QA/QC

Comparing SDS-PAGE and CE-SDS for Antibody Purity Analysis

Apr 1, 2014

byDahai Dong, Jichao Kang

Webinars

Ask the Expert webcasts

ATE Webcasts

Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process

Event Report

Exclusive eBook

eBook: Biotech Week Boston Post-event Report

Read Now

Insider News

Alois Jungbauer: A life in biotechnology
Feb 3, 2025
|
3 Min Read
Don’t Speke! AstraZeneca turns back on £450m UK vaccine plant
Feb 3, 2025
|
2 Min Read
Rentschler pulls out of CGT business
Jan 31, 2025
|
2 Min Read
Sartorius eyes long-term growth amid market fluctuations
Jan 30, 2025
|
2 Min Read

See all

Mar 18 - Mar 21, 2025

SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.

Learn More